Literature DB >> 20224072

Cigarette smoke decreases innate responses of epithelial cells to rhinovirus infection.

Jane Eddleston1, Rachel U Lee, Astrid M Doerner, Jack Herschbach, Bruce L Zuraw.   

Abstract

Exposure to cigarette smoke is associated with a significant increase in the risk for respiratory viral infections. The airway epithelium is the primary target for both cigarette smoke and respiratory viral infection. We investigated the effects of cigarette smoke on the response of airway epithelial cells to rhinovirus infection. We found that pre-exposure of BEAS-2B cells or primary normal human bronchial epithelial cells (NHBEs) to cigarette smoke extract (CSE) reduced the induction of mRNA of the chemokines CXCL10 and CCL5 by either the viral mimic polyinosine-polycytidylic acid (Poly I:C) or human rhinovirus 16 (HRV-16) infection. The HRV-16-induced release of CXCL10 and CCL5 was also significantly suppressed by CSE. Activation of the IFN mediator STAT-1 and the activation of JNK by poly I:C and HRV-16 were partially suppressed by pre-exposure to CSE. In contrast, the poly I:C-induced and HRV-16-induced phosphorylation of ERK1/2 was unaffected by CSE. HRV-16-stimulated IFN-β mRNA was also significantly reduced by CSE. Because suppression of the IFN response to viral infection was associated with increased viral production, we assessed HRV-16 RNA concentrations. Exposure to CSE resulted in an increase in HRV-16 RNA at 48 hours after the infection of BEAS-2B cells. These data demonstrate that exposure to CSE alters the response of airway epithelial cells to HRV infection, leading to decreased activation of the IFN-STAT-1 and SAP-JNK pathways, the suppression of CXCL10 and CCL5 production, and increased viral RNA. A diminished, early epithelial-initiated antiviral response to rhinovirus infection could contribute to the increased susceptibility of subjects to prolonged respiratory viral infections after exposure to cigarette smoke.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20224072      PMCID: PMC3028255          DOI: 10.1165/rcmb.2009-0266OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  55 in total

1.  Suppression of human IL-1beta, IL-2, IFN-gamma, and TNF-alpha production by cigarette smoke extracts.

Authors:  Y Ouyang; N Virasch; P Hao; M T Aubrey; N Mukerjee; B E Bierer; B M Freed
Journal:  J Allergy Clin Immunol       Date:  2000-08       Impact factor: 10.793

2.  Resistance of differentiated human airway epithelium to infection by rhinovirus.

Authors:  N Lopez-Souza; G Dolganov; R Dubin; L A Sachs; L Sassina; H Sporer; S Yagi; D Schnurr; H A Boushey; J H Widdicombe
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-02       Impact factor: 5.464

Review 3.  Acute effects of cigarette smoke on inflammation and oxidative stress: a review.

Authors:  H van der Vaart; D S Postma; W Timens; N H T ten Hacken
Journal:  Thorax       Date:  2004-08       Impact factor: 9.139

Review 4.  How cigarette smoke skews immune responses to promote infection, lung disease and cancer.

Authors:  Martin R Stämpfli; Gary P Anderson
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

5.  Suppression of pulmonary innate host defence in smokers.

Authors:  C Herr; C Beisswenger; C Hess; K Kandler; N Suttorp; T Welte; J-M Schroeder; C Vogelmeier
Journal:  Thorax       Date:  2008-10-13       Impact factor: 9.139

6.  Selective transcriptional down-regulation of human rhinovirus-induced production of CXCL10 from airway epithelial cells via the MEK1 pathway.

Authors:  Raza S Zaheer; Rommy Koetzler; Neil S Holden; Shahina Wiehler; David Proud
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

7.  Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).

Authors:  Matthew B Elliott; Paul W Tebbey; Karin S Pryharski; Catherine A Scheuer; Todd S Laughlin; Gerald E Hancock
Journal:  J Med Virol       Date:  2004-06       Impact factor: 2.327

8.  Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice.

Authors:  Min-Jong Kang; Chun Geun Lee; Jae-Young Lee; Charles S Dela Cruz; Zhijian J Chen; Richard Enelow; Jack A Elias
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

9.  Effects of cigarette smoke on the human airway epithelial cell transcriptome.

Authors:  Avrum Spira; Jennifer Beane; Vishal Shah; Gang Liu; Frank Schembri; Xuemei Yang; John Palma; Jerome S Brody
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

10.  In vitro modeling of human alveolar macrophage smoke exposure: enhanced inflammation and impaired function.

Authors:  Aaron R Winkler; Karl H Nocka; Timothy H Sulahian; Lester Kobzik; Cara M M Williams
Journal:  Exp Lung Res       Date:  2008-11       Impact factor: 2.459

View more
  37 in total

1.  Cost Analysis of Motivational Interviewing and Preschool Education for Secondhand Smoke Exposures.

Authors:  Mandeep S Jassal; Kristin A Riekert; Belinda Borrelli; Cynthia S Rand; Michelle N Eakin
Journal:  Nicotine Tob Res       Date:  2016-01-22       Impact factor: 4.244

2.  Cigarette smoke attenuates the RIG-I-initiated innate antiviral response to influenza infection in two murine models.

Authors:  Wenxin Wu; Wei Zhang; Sunil More; J Leland Booth; Elizabeth S Duggan; Lin Liu; Yan D Zhao; Jordan P Metcalf
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-09-26       Impact factor: 5.464

3.  Two interferon-independent double-stranded RNA-induced host defense strategies suppress the common cold virus at warm temperature.

Authors:  Ellen F Foxman; James A Storer; Kiran Vanaja; Andre Levchenko; Akiko Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-11       Impact factor: 11.205

Review 4.  Mitochondria: at the crossroads of regulating lung epithelial cell function in chronic obstructive pulmonary disease.

Authors:  Mahyar Aghapour; Alexander H V Remels; Simon D Pouwels; Dunja Bruder; Pieter S Hiemstra; Suzanne M Cloonan; Irene H Heijink
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-06       Impact factor: 5.464

Review 5.  The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19.

Authors:  Ali Ehsan Sifat; Saeideh Nozohouri; Heidi Villalba; Bhuvaneshwar Vaidya; Thomas J Abbruscato
Journal:  J Pharmacol Exp Ther       Date:  2020-10-08       Impact factor: 4.030

6.  Regulation and activity of secretory leukoprotease inhibitor (SLPI) is altered in smokers.

Authors:  Megan Meyer; Rebecca N Bauer; Blanche D Letang; Luisa Brighton; Elizabeth Thompson; Rosalia C M Simmen; James Bonner; Ilona Jaspers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-27       Impact factor: 5.464

7.  Cigarette smoke increases BLT2 receptor functions in bronchial epithelial cells: in vitro and ex vivo evidence.

Authors:  Elisabetta Pace; Maria Ferraro; Serena Di Vincenzo; Andreina Bruno; Antonino Giarratano; Valeria Scafidi; Luana Lipari; Denise Valentina Di Benedetto; Serafina Sciarrino; Mark Gjomarkaj
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

8.  NOD1 agonist iE-DAP reverses effects of cigarette smoke extract on NOD1 signal pathway in human oral mucosal epithelial cells.

Authors:  Yafan Gao; Wenhui Jiang; Yajie Qian; Qian Zhou; Hongliu Jiang; Xiang Wang; Wenmei Wang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

9.  Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk.

Authors:  Nadine Kabbani; James L Olds
Journal:  Mol Pharmacol       Date:  2020-04-01       Impact factor: 4.436

10.  Cigarette smoke modulates expression of human rhinovirus-induced airway epithelial host defense genes.

Authors:  David Proud; Magdalena H Hudy; Shahina Wiehler; Raza S Zaheer; Minaa A Amin; Jonathan B Pelikan; Claire E Tacon; Tabitha O Tonsaker; Brandie L Walker; Cora Kooi; Suzanne L Traves; Richard Leigh
Journal:  PLoS One       Date:  2012-07-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.